|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.081 USD | -2.65% |
|
-2.68% | -72.54% |
| 05/04 | China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| 08/02 | Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected | MT |
China SXT Pharmaceuticals, Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was USD 1.97 million compared to USD 2.6 million a year ago. Revenue was USD 1.97 million compared to USD 2.6 million a year ago.
Net loss was USD 5.93 million compared to USD 5.74 million a year ago. Basic loss per share from continuing operations was USD 22.225 compared to USD 137.925 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -72.54% | 808K | |
| +31.37% | 588B | |
| -2.83% | 364B | |
| +20.34% | 326B | |
| +5.47% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +11.16% | 167B | |
| -0.07% | 161B |
CHINA SXT PHARMACEUTICALS, INC. 
